RJA
BMEZ icon

Raymond James & Associates’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Raymond James & Associates’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.06M Buy
508,606
+123
+0% +$1.94K ﹤0.01% 1351
2024
Q2 		$7.81M Sell
508,483
-1,713
-0.3% -$26K 0.01% 1309
2024
Q1 		$8.36M Sell
510,196
-5,765
-1% -$90.9K 0.01% 1263
2023
Q4 		$7.56M Sell
515,961
-35,673
-6% -$498K 0.01% 1280
2023
Q3 		$7.95M Sell
551,634
-227,181
-29% -$3.54M 0.01% 1178
2023
Q2 		$12.8M Sell
778,815
-22,385
-3% -$365K 0.01% 919
2023
Q1 		$13.4M Sell
801,200
-43,710
-5% -$704K 0.01% 871
2022
Q4 		$13M Sell
844,910
-105,887
-11% -$1.64M 0.01% 861
2022
Q3 		$14.2M Sell
950,797
-204,582
-18% -$3.38M 0.01% 770
2022
Q2 		$19M Buy
1,155,379
+115,958
+11% +$1.99M 0.02% 635
2022
Q1 		$20.9M Buy
1,039,421
+230,216
+28% +$4.78M 0.02% 679
2021
Q4 		$20.5M Sell
809,205
-64,421
-7% -$1.66M 0.02% 732
2021
Q3 		$23.6M Sell
873,626
-7,513
-0.9% -$215K 0.02% 619
2021
Q2 		$25.5M Buy
881,139
+8,606
+1% +$238K 0.02% 593
2021
Q1 		$22.9M Buy
872,533
+223,818
+35% +$6.35M 0.02% 604
2020
Q4 		$18.6M Sell
648,715
-11,775
-2% -$313K 0.02% 650
2020
Q3 		$15.8M Buy
660,490
+39,861
+6% +$919K 0.02% 641
2020
Q2 		$13M Buy
620,629
+50,414
+9% +$993K 0.02% 696
2020
Q1 		$10.2M Buy
+570,215
New +$11M 0.02% 741

Other funds holding BMEZ

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James & Associates's BMEZ Position: Q3 2024 in Review

Raymond James & Associates increased its BlackRock Health Sciences Trust II (BMEZ) stake by 0.02% in Q3 2024, buying an estimated $1.94K and bringing the position to 508,606 shares worth $8.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Raymond James & Associates first reported a position in BMEZ in Q1 2020 and has held it in 19 quarters since. The position peaked at $25.5M in Q2 2021. 92 funds tracked by Wall St. Rank hold BMEZ as of Q3 2024.

  • Raymond James & Associates held 508,606 shares of BlackRock Health Sciences Trust II worth $8.06M as of Q3 2024.
  • Raymond James & Associates bought 123 BlackRock Health Sciences Trust II shares in Q3 2024, an estimated $1.94K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1351 holding.
  • Raymond James & Associates first reported a position in BlackRock Health Sciences Trust II in Q1 2020 and has held it in 19 quarters since.
  • Raymond James & Associates's BlackRock Health Sciences Trust II position peaked at $25.5M in Q2 2021.
  • 92 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.